All peptides are prescribed based on individual health assessments and lab work
A post-hoc subgroup analysis of that trial suggested benefit of prasinezumab in subjects with faster progression [209] and a comparison of MDS-UPDRS progression during the 4-year open-label extension phase with historical controls showed divergent trajectories in favour of prasinezumab from year 2 of treatment onwards [210]
On his podcast, Andrew Huberman, MD, professor of neurobiology and ophthalmology at Stanford Universitys school of medicine, shared a potential, and slightly gory, origin story for BPC-157
Timothy Fensky , RPhcompounding pharmacist and consultant
This particular early noxious effect of isoprenaline has not been investigated so far, but it can be likely antagonized by BPC 157 therapy application
For 100 mg + 3 ml bacteriostatic water: Concentration = 33 mg/ml 0.1 ml = 3.3 mg